Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 724

1.

Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.

Yoshida A, Wakai S, Ryo E, Miyata K, Miyazawa M, Yoshida KI, Motoi T, Ogawa C, Iwata S, Kobayashi E, Watanabe SI, Kawai A, Mori T.

Am J Surg Pathol. 2019 Jul 11. doi: 10.1097/PAS.0000000000001331. [Epub ahead of print]

PMID:
31305268
2.

Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.

Yoshida KI, Nakano Y, Honda-Kitahara M, Wakai S, Motoi T, Ogura K, Sano N, Shibata T, Okuma T, Iwata S, Kawai A, Ichimura K, Yoshida A.

Mod Pathol. 2019 Jul 8. doi: 10.1038/s41379-019-0318-5. [Epub ahead of print]

PMID:
31285528
3.

Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.

Sekimizu M, Ogura K, Yasunaga H, Matsui H, Tanaka S, Inagaki K, Kawai A.

BMC Cancer. 2019 Jul 4;19(1):657. doi: 10.1186/s12885-019-5875-y.

4.

Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification.

Chikamatsu K, Aono A, Kawai A, Hata H, Iwamoto T, Igarashi Y, Takaki A, Yamada H, Mitarai S.

J Microbiol Methods. 2019 Aug;163:105657. doi: 10.1016/j.mimet.2019.105657. Epub 2019 Jun 19.

PMID:
31228476
5.

Validation of febrile seizures identified in the Sentinel Post-Licensure Rapid Immunization Safety Monitoring Program.

Kawai AT, Martin D, Henrickson SE, Goff A, Reidy M, Santiago D, Selvam N, Selvan M, McMahill-Walraven C, Lee GM.

Vaccine. 2019 Jul 9;37(30):4172-4176. doi: 10.1016/j.vaccine.2019.05.042. Epub 2019 Jun 8.

PMID:
31186192
6.

Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.

Nagano A, Matsumoto S, Kawai A, Okuma T, Hiraga H, Matsumoto Y, Nishida Y, Yonemoto T, Hosaka M, Takahashi M, Yoshikawa H, Kunisada T, Asanuma K, Naka N, Emori M, Kubo T, Kawashima H, Kawamoto T, Yokoyama R, Tsukushi S, Sato K, Okamoto T, Hiraoka K, Morioka H, Tanaka K, Takagi T, Iwamoto Y, Ozaki T.

J Orthop Sci. 2019 May 30. pii: S0949-2658(19)30128-9. doi: 10.1016/j.jos.2019.04.008. [Epub ahead of print]

PMID:
31155441
7.

A clinical comparison between dedifferentiated low-grade osteosarcoma and conventional osteosarcoma.

Toki S, Kobayashi E, Yoshida A, Ogura K, Wakai S, Yoshimoto S, Yonemori K, Kawai A.

Bone Joint J. 2019 Jun;101-B(6):745-752. doi: 10.1302/0301-620X.101B6.BJJ-2018-1207.R1.

PMID:
31154837
8.

Determination of iris thickness development in children using swept-source anterior-segment optical coherence tomography.

Nakakura S, Nagata Y, Shimizu Y, Kawai A, Tabuchi H, Kiuchi Y.

PLoS One. 2019 May 28;14(5):e0217656. doi: 10.1371/journal.pone.0217656. eCollection 2019.

9.

KMT2A (MLL) fusions in aggressive sarcomas in young adults.

Yoshida A, Arai Y, Tanzawa Y, Wakai S, Hama N, Kawai A, Shibata T.

Histopathology. 2019 May 28. doi: 10.1111/his.13926. [Epub ahead of print]

PMID:
31136005
10.

PML-RARα induces all-trans retinoic acid-dependent transcriptional activation through interaction with MED1.

Fukuoka T, Kawai A, Takahara T, Mori M, Roeder RG, Hasegawa N, Ito M.

Transcription. 2019 Jun;10(3):147-156. doi: 10.1080/21541264.2019.1624467. Epub 2019 Jun 5.

PMID:
31135261
11.

Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.

Tsuda Y, Hirata M, Katayama K, Motoi T, Matsubara D, Oda Y, Fujita M, Kobayashi H, Kawano H, Nishida Y, Sakai T, Okuma T, Goto T, Ogura K, Kawai A, Ae K, Anazawa U, Suehara Y, Iwata S, Miyano S, Imoto S, Shibata T, Nakagawa H, Yamaguchi R, Tanaka S, Matsuda K.

Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32421. [Epub ahead of print]

PMID:
31107544
12.

Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion.

Makise N, Sekimizu M, Kobayashi E, Yoshida H, Fukayama M, Kato T, Kawai A, Ichikawa H, Yoshida A.

Virchows Arch. 2019 May 17. doi: 10.1007/s00428-019-02588-8. [Epub ahead of print]

PMID:
31101969
13.

Minimal clinically important differences in Toronto Extremity Salvage Score for patients with lower extremity sarcoma.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2019 Apr 16. pii: S0949-2658(19)30118-6. doi: 10.1016/j.jos.2019.03.022. [Epub ahead of print]

PMID:
31000377
14.

Association between change in self-efficacy and reduction in disability among patients with chronic pain.

Karasawa Y, Yamada K, Iseki M, Yamaguchi M, Murakami Y, Tamagawa T, Kadowaki F, Hamaoka S, Ishii T, Kawai A, Shinohara H, Yamaguchi K, Inada E.

PLoS One. 2019 Apr 16;14(4):e0215404. doi: 10.1371/journal.pone.0215404. eCollection 2019.

15.

Calreticulin as A Novel Potential Metastasis-Associated Protein in Myxoid Liposarcoma, as Revealed by Two-Dimensional Difference Gel Electrophoresis.

Tajima T, Kito F, Yoshida A, Kawai A, Kondo T.

Proteomes. 2019 Apr 10;7(2). pii: E13. doi: 10.3390/proteomes7020013.

16.

[Ⅰ.New TNM Classification of Bone and Soft Tissue Sarcoma-Changes between the 7th and 8th Editions].

Mori T, Kobayashi E, Kawai A.

Gan To Kagaku Ryoho. 2019 Mar;46(3):433-436. Japanese. No abstract available.

PMID:
30914579
17.

[Musculoskeletal Tumor Recent Topics in Musculoskeletal Tumors(Sarcomas)].

Kawai A.

Gan To Kagaku Ryoho. 2019 Mar;46(3):432. Japanese. No abstract available.

PMID:
30914578
18.

A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.

Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T.

Nat Commun. 2019 Mar 21;10(1):1299. doi: 10.1038/s41467-019-09143-8.

19.

A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.

Urakawa H, Mizusawa J, Tanaka K, Eba J, Hiraga H, Kawai A, Nishida Y, Hosaka M, Iwamoto Y, Fukuda H, Ozaki T.

Jpn J Clin Oncol. 2019 Apr 1;49(4):379-382. doi: 10.1093/jjco/hyz004.

PMID:
30796832
20.

Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro.

Kobayshi K, Abe Y, Kawai A, Furihata T, Harada H, Endo T, Takeda H.

Xenobiotica. 2019 Feb 12:1-13. doi: 10.1080/00498254.2019.1580796. [Epub ahead of print]

PMID:
30747023
21.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

22.

Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.

Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T.

Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. Epub 2019 Feb 8.

PMID:
30737713
23.

Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.

Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T.

Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8.

PMID:
30737712
24.

A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.

Kim R, Kawai A, Wakisaka M, Funaoka Y, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Arihiro K.

Cancer Immunol Immunother. 2019 Apr;68(4):577-585. doi: 10.1007/s00262-019-02305-z. Epub 2019 Jan 23.

PMID:
30673828
25.

Flap reconstruction after groin and medial thigh sarcoma resection reduces the risk of lower-extremity lymphedema.

Tashiro K, Arikawa M, Kagaya Y, Kobayashi E, Kawai A, Miyamoto S.

J Plast Reconstr Aesthet Surg. 2019 Apr;72(4):685-710. doi: 10.1016/j.bjps.2019.01.009. Epub 2019 Jan 12. No abstract available.

PMID:
30661914
26.

Analysis of mutations in primary and metastatic synovial sarcoma.

Xing Z, Wei L, Jiang X, Conroy J, Glenn S, Bshara W, Yu T, Pao A, Tanaka S, Kawai A, Choi C, Wang J, Liu S, Morrison C, Yu YE.

Oncotarget. 2018 Dec 7;9(96):36878-36888. doi: 10.18632/oncotarget.26416. eCollection 2018 Dec 7.

27.

Frequent mutations of genes encoding vacuolar H+ -ATPase components in granular cell tumors.

Sekimizu M, Yoshida A, Mitani S, Asano N, Hirata M, Kubo T, Yamazaki F, Sakamoto H, Kato M, Makise N, Mori T, Yamazaki N, Sekine S, Oda I, Watanabe SI, Hiraga H, Yonemoto T, Kawamoto T, Naka N, Funauchi Y, Nishida Y, Honoki K, Kawano H, Tsuchiya H, Kunisada T, Matsuda K, Inagaki K, Kawai A, Ichikawa H.

Genes Chromosomes Cancer. 2019 Jun;58(6):373-380. doi: 10.1002/gcc.22727. Epub 2019 Jan 21.

PMID:
30597645
28.

Effectiveness of Preceding Solo Kidney Transplantation for Type 1 Diabetes With End-Stage Renal Failure.

Ito T, Kenmochi T, Aida N, Kurihara K, Kawai A, Ito T.

Transplant Proc. 2018 Dec;50(10):3249-3254. doi: 10.1016/j.transproceed.2018.06.014. Epub 2018 Jun 22.

PMID:
30577193
29.

Novel NTRK3 Fusions in Fibrosarcomas of Adults.

Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu M, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2019 Apr;43(4):523-530. doi: 10.1097/PAS.0000000000001194.

PMID:
30520818
30.

Warm ischemic time as a critical risk factor of graft failure from donors after cardiac death: A single-center experience over three decades in the Kidney Donor Profile Index/Kidney Donor Risk Index era in Japan.

Kusaka M, Kubota Y, Takahashi H, Sasaki H, Kawai A, Takenaka M, Fukami N, Kenmochi T, Shiroki R, Hoshinaga K.

Int J Urol. 2019 Feb;26(2):247-252. doi: 10.1111/iju.13851. Epub 2018 Nov 20.

PMID:
30460731
31.

Development of a patient-oriented disease specific outcome measure of health-related quality of life (HRQOL) for musculoskeletal oncology patients.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2019 May;24(3):539-547. doi: 10.1016/j.jos.2018.10.020. Epub 2018 Nov 13.

PMID:
30446332
32.

Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan.

Kawai T, Kusano Y, Yamada K, Ueda C, Kawai A, Masaki T.

J Artif Organs. 2019 Jun;22(2):146-153. doi: 10.1007/s10047-018-1080-z. Epub 2018 Nov 14.

PMID:
30426250
33.

Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.

Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.

In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. Epub 2018 Nov 8.

PMID:
30411273
34.

Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure.

Sakurama K, Kawai A, Tuan Giam Chuang V, Kanamori Y, Osa M, Taguchi K, Seo H, Maruyama T, Imoto S, Yamasaki K, Otagiri M.

ACS Omega. 2018 Oct 31;3(10):13790-13797. doi: 10.1021/acsomega.8b02057. Epub 2018 Oct 22.

35.

A Cost Effective Easy Competitive Enzyme-Linked Immunosorbent Assay Suitable for Monitoring Protective Immunity against the Rabies Virus in the Serum of Humans and Dogs.

Aronthippaitoon Y, Samer W, Atuntee T, Thananchai H, Thongkorn K, Pongsopawijit P, Inoue S, Noguchi A, Park ES, Kawai A, Petsophonsakul W.

Jpn J Infect Dis. 2019 Mar 25;72(2):99-105. doi: 10.7883/yoken.JJID.2018.248. Epub 2018 Oct 31.

36.

Correction to: Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1212-1216. doi: 10.1007/s10147-018-1342-z.

PMID:
30324312
37.

Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1.

Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T.

In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15.

PMID:
30324244
38.

Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.

Koike H, Nishida Y, Kohno K, Shimoyama Y, Motoi T, Hamada S, Kawai A, Ogose A, Ozaki T, Kunisada T, Matsumoto Y, Matsunobu T, Ae K, Gokita T, Sakai T, Shimizu K, Ishiguro N.

Hum Pathol. 2019 Feb;84:155-163. doi: 10.1016/j.humpath.2018.09.018. Epub 2018 Oct 5.

PMID:
30292627
39.

H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.

Makise N, Sekimizu M, Konishi E, Motoi T, Kubo T, Ikoma H, Watanabe SI, Okuma T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Mod Pathol. 2019 Mar;32(3):435-445. doi: 10.1038/s41379-018-0140-5. Epub 2018 Oct 5.

PMID:
30291346
40.

Free latissimus dorsi musculocutaneous flap for external hemipelvectomy reconstruction.

Tashiro K, Arikawa M, Fukunaga Y, Nakatani F, Kobayashi E, Kawai A, Miyamoto S.

Microsurgery. 2019 Feb;39(2):138-143. doi: 10.1002/micr.30373. Epub 2018 Sep 6.

PMID:
30191595
41.

Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates.

Rhee C, Wang R, Jentzsch MS, Hsu H, Kawai AT, Jin R, Horan K, Broadwell C, Lee GM.

Open Forum Infect Dis. 2018 Sep 4;5(9):ofy204. doi: 10.1093/ofid/ofy204. eCollection 2018 Sep.

42.

Successful Pregnancy and Delivery after Autologous Abdominal Wall Reconstruction using Anterolateral-Thigh and Iliotibial-Tract Flap.

Kagaya Y, Arikawa M, Kobayashi E, Kawai A, Miyamoto S.

Plast Reconstr Surg Glob Open. 2018 Jul 13;6(7):e1819. doi: 10.1097/GOX.0000000000001819. eCollection 2018 Jul.

43.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A.

BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

44.

Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304.

Tanaka K, Ogawa G, Mizusawa J, Naka N, Kawai A, Takahashi M, Hiruma T, Matsumoto Y, Tsuchiya H, Nakayama R, Hatano H, Emori M, Hosaka M, Yoshida Y, Toguchida J, Abe S, Asanuma K, Yokoyama R, Hiraga H, Yonemoto T, Morii T, Matsumoto S, Nagano A, Yoshikawa H, Fukuda H, Ozaki T, Iwamoto Y.

World J Surg Oncol. 2018 Aug 10;16(1):162. doi: 10.1186/s12957-018-1462-y.

45.

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.

Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.

World J Surg Oncol. 2018 Aug 8;16(1):160. doi: 10.1186/s12957-018-1459-6.

46.

Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1201-1211. doi: 10.1007/s10147-018-1323-2. Epub 2018 Jul 30. Erratum in: Int J Clin Oncol. 2018 Oct 15;:.

PMID:
30062493
47.

Integrated genetic and epigenetic analysis of myxofibrosarcoma.

Ogura K, Hosoda F, Arai Y, Nakamura H, Hama N, Totoki Y, Yoshida A, Nagai M, Kato M, Arakawa E, Mukai W, Rokutan H, Kawai A, Tanaka S, Shibata T.

Nat Commun. 2018 Jul 17;9(1):2765. doi: 10.1038/s41467-018-03891-9.

49.

Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line.

Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T.

In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25.

PMID:
29943355
50.

PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.

Toki S, Wakai S, Sekimizu M, Mori T, Ichikawa H, Kawai A, Yoshida A.

Histopathology. 2018 Oct;73(4):645-652. doi: 10.1111/his.13689. Epub 2018 Aug 2.

PMID:
29920735

Supplemental Content

Support Center